Caas Capital Management LP Gsk PLC Transaction History
Caas Capital Management LP
- $552 Million
- Q4 2024
A detailed history of Caas Capital Management LP transactions in Gsk PLC stock. As of the latest transaction made, Caas Capital Management LP holds 6,900 shares of GSK stock, worth $243,363. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,900Holding current value
$243,363% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GSK
# of Institutions
21Shares Held
177KCall Options Held
0Put Options Held
0-
Boenning & Scattergood, Inc.43.3KShares$1.53 Million0.3% of portfolio
-
Altium Wealth Management LLC33.4KShares$1.18 Million0.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA20KShares$704,9410.06% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL18.6KShares$656,3740.0% of portfolio
-
Loveless Wealth Management LLC15KShares$529,4020.43% of portfolio
About GSK PLC
- Ticker GSK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,033,689,984
- Market Cap $71.7B
- Description
- GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...